I Didn’t Set Out to Build a Company So, here is my story. You see, when I started this journey, I wasn’t trying to build a startup. that was not in my mind. I am retired and live simple... no tension and no endless business meetings. I just wanted to code an engine with modern tools. I wasn’t chasing venture capital. I wasn’t thinking about pricing tiers, TAM, or business plans. Shoot! I am not even good at writing a business plan. I had a much simpler and much harder goal: I

As of today, I have quietly moved 478,808 virtual Compounds through a quantum-enhanced drug discovery machine in my back office in Oklahoma. Today I hit a nice milestone on the Citizen Scientist  page of QuantumCURE Pro™  and the numbers made me smile, so I’m sharing them. The Raw Numbers Compounds processed (Citizen Scientist):  478,808 Compounds that made it into the Golden List:  30 Hit rate: What does that mean? In industry, typical virtual screening or HTS hit rates ar

QuantumCURE Pro ™ screen shots - Round two of QuantumCURE pro™ software validation is officially in the books. Some people pick up fishing or golf in retirement. I enjoy those too, but for the last few years I’ve been teaching myself quantum computing, cheminformatics, and how to build full cancer drug discovery portals. Why? People ask me that a lot. My answer is simple: why not? I want to be useful, and I still have work to do. I sit in a cold Oklahoma garage, lift heavy

I saw an MIT study tonight about AI and job losses, and that is alarming. So,  AI can already replace % 11. 7% of US jobs....and workforce, but what the MIT “11.7%” really is: So, MIT + Oak Ridge built a model called the Iceberg Index  that looks at: 151M U.S. workers 900+ occupations 32,000+ skills They asked: “With AI that exists today , what fraction of current work tasks could AI technically do?” Their answer: AI is already capable of doing tasks equal to 11.7% of tot

Companies like Schrödinger and Atomwise have incredible platforms, but their primary business is selling software and partnering with major pharmaceutical companies. They provide powerful tools  and co-discovery services; their partners own most of the downstream pipeline and wet-lab risk. Schrödinger+1 I built QuantumCURE  with a different mission: not just to rank molecules, but to actually walk a set of compounds all the way into a wet list I own and can defend . In less t

What if cancer drug discovery wasn’t limited to billion-dollar pharma labs? From my back office in Oklahoma, I’ve built QuantumCURE  — a molecular docking and retrosynthesis platform that uses AI, open pipelines, and quantum entropy  to explore chemical spaces classical systems often miss. In this video, I explain: Why quantum randomness  changes the search space in simulations How docking with AutoDock Vina  and free protein prep tools (PDBFixer, PDB2PQR) works The role of A

Hey! You might be wondering — what’s really going on under the hood in the QuantumCURE software I’ve been building? What am I actually doing here? And honestly, what the hell is molecular docking anyway? First things first: if you scroll down and read my disclaimer, you’ll know exactly what I’m not  doing. I’m not a chemist. I’m not a physicist. I don’t work for big pharma. What I am  is a passionate software and systems designer. I understand the moving parts of drug discove

Molecular Docking Software Design from a Computer Programmer’s Perspective It took me 7-8 months to build a working drug discovery system...

quantumtornado.org - QuantumCURE drug discovery system. quantumtornado.org QuantumCURE: Quantum-Enhanced Molecular Docking at Scale By...

Quantum Entropy in Drug Discovery: A New Era of Symbolic Insight By Mansour Ansari, Founder of QuantumLaso I Built a Quantum-Powered...

I have in my lab a small but profound piece of hardware — a USB quantum random number generator (QRNG) made by Pycalabs, connected to...

A new Drug for Cancer? While immersed in my https://quantumtornado.org/ project — a system designed to predict tornadoes by injecting...